The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Standard-dose vs fixed-dose capecitabine in patients with advanced gastrointestinal and metastatic breast cancer.
 
Nanuli Gvazava
No Relationships to Disclose
 
Qamar Khan
No Relationships to Disclose
 
Lauren Clark
No Relationships to Disclose
 
Joaquina Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Merus; Moderna Therapeutics; Novo Nordisk; Zymeworks
Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); Genentech/Roche (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)
 
Priyanka Sharma
Stock and Other Ownership Interests - Amgen; Gilead Sciences (I); Johnson & Johnson/Janssen; Pfizer (I); Roche/Genentech (I); Sanofi
Consulting or Advisory Role - AstraZeneca; Boston Scientific (I); Cipla (I); Gilead Sciences; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Salient Pharmaceuticals (I); Sanofi; Stemline Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Taylor Monson
Consulting or Advisory Role - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Milind Phadnis
No Relationships to Disclose
 
Colleen Bohnenkamp
Employment - Menarini Group
Consulting or Advisory Role - GlaxoSmithKline
 
Anne O'Dea
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Pfizer; Puma Biotechnology; Stemline Therapeutics
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Puma Biotechnology; Seagen; Stemline Therapeutics
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Pfizer; Puma Biotechnology; Stemline Therapeutics
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Pfizer; Puma Biotechnology; Stemline Therapeutics
 
Manana Elia
Stock and Other Ownership Interests - BioNTech SE; Lilly (I)
Consulting or Advisory Role - Gilead Sciences
 
Lauren Nye
Consulting or Advisory Role - bioTheranostics; Myriad Genetic Laboratories
Travel, Accommodations, Expenses - Ambry Genetics
 
Robert Pluenneke
No Relationships to Disclose
 
Laura Mitchell
No Relationships to Disclose
 
Raed Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Mark Fesen
No Relationships to Disclose
 
Stephanie LaFaver
No Relationships to Disclose
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)